Why the study?
Does the introduction of the new inactivated poliovirus vaccine (IPV) improve vaccination coverage and efficacy/cost ratio compared to the oral poliovirus vaccine in children in the Expanded Programme on Immunization?
Population
Children in the Expanded Programme on Immunization (EPI)
Comparison
New inactivated poliovirus vaccine (IPV) vs Oral poliovirus vaccine (OPV)
Design
Review
Authors
Loading...
May support two-visit IPV schedules to boost EPI coverage; leaves open prospective trials to confirm gains.
Does the introduction of the new inactivated poliovirus vaccine (IPV) improve vaccination coverage and efficacy/cost ratio compared to the oral poliovirus vaccine in children in the Expanded Programme on Immunization?
The introduction of the new IPV into the EPI improves vaccination coverage and the efficacy/cost ratio by reducing the required number of visits from four to two.
J.F García Martín (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: